HA
MNTA

Havens Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Havens Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-107,000
Closed -$5.62M – 52
2020
Q3 		$5.62M Buy
+107,000
New +$4.43M 5.2% 9

Havens Advisors's MNTA Position: Q4 2020 in Review

Havens Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 107,000 shares — an estimated $5.62M sold.

Havens Advisors first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $5.62M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Havens Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Havens Advisors sold 107,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.62M.
  • Havens Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Havens Advisors's Momenta Pharmaceuticals, Inc. position peaked at $5.62M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Havens Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.